Dilon Devices Appoints William Densel President U.S. and Chief Business Officer

[vc_row][vc_column][vc_column_text]Caesarea, Israel and New York, NY, March 12, 2009 – Dilon Devices, a developer of cancer detection devices, today announced the appointment of William Densel as President U.S. and Chief Business Officer. Dilon Devices is engaged in the development and commercialization of intraoperative devices for the real-time detection of cancerous tissues. The company’s initial product,…

Read More